Samuels Noah, Freed Yakov, Weitzen Rony, Ben-David Merav, Maimon Yair, Eliyahu Uri, Berger Raanan
1 Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel.
2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Integr Cancer Ther. 2018 Jun;17(2):486-492. doi: 10.1177/1534735417736133. Epub 2017 Nov 2.
Homeopathy has the potential to reduce symptoms related to cancer treatment. The present study examined the feasibility of a homeopathic consultation and treatment program, provided as part of an integrative oncology service.
The electronic medical files of patients undergoing a homeopathic consultation in an integrative oncology service clinic were examined retrospectively. Adherence to the homeopathic treatment regimen and perceived response to the treatment were evaluated.
The files of 124 patient (34 males, 90 females) were examined, of which two-thirds reported acquiring and self-administering the homeopathic remedy as prescribed, and nearly three-quarters reporting a beneficial effect. Adherence to the homeopathic treatment regimen was greatest among patients attending a second visit, as opposed to having only telephone/e-mail follow-up ( P < .005). An association was found between a perceived beneficial effect of treatment with attending a follow-up visit ( P = .04), female gender ( P = .02), younger age ( P = .048), diagnosis of breast cancer ( P = .014), and current radiation treatment (vs chemotherapy; P = .003). Patients reporting chemotherapy-induced peripheral neuropathy were also more likely to report a beneficial effect ( P = .004), as were female patients reporting hot flashes ( P = .005) and those referred by an oncologist ( P = .046). No adverse effects were attributed to the homeopathic treatment.
Homeopathy can be successfully incorporated within a supportive care integrative oncology service. In addition to demographic and cancer-related characteristics, as well as symptoms, patients attending a second visit (vs only telephone/e-mail follow-up) were more likely to adhere to and perceive a beneficial effect from the homeopathic regimen.
顺势疗法有减轻癌症治疗相关症状的潜力。本研究探讨了顺势疗法咨询与治疗方案作为综合肿瘤服务一部分的可行性。
回顾性分析在综合肿瘤服务诊所接受顺势疗法咨询的患者的电子病历。评估对顺势疗法治疗方案的依从性以及对治疗的感知反应。
检查了124例患者(34例男性,90例女性)的病历,其中三分之二报告按处方获取并自行服用顺势疗法药物,近四分之三报告有有益效果。与仅通过电话/电子邮件随访的患者相比,复诊患者对顺势疗法治疗方案的依从性最高(P < 0.005)。发现治疗的感知有益效果与复诊(P = 0.04)、女性性别(P = 0.02)、较年轻年龄(P = 0.048)、乳腺癌诊断(P = 0.014)以及当前接受放射治疗(与化疗相比;P = 0.003)之间存在关联。报告有化疗引起的周围神经病变的患者也更有可能报告有有益效果(P = 0.004),报告有潮热的女性患者(P = 0.005)以及由肿瘤学家转诊的患者(P = 0.046)也是如此。未发现顺势疗法治疗有不良反应。
顺势疗法可成功纳入支持性综合肿瘤服务。除了人口统计学和癌症相关特征以及症状外,复诊患者(与仅通过电话/电子邮件随访相比)更有可能坚持顺势疗法方案并感知到有益效果。